Protective effects of erythropoietin on lipid metabolism in the liver of ob/ob mice

Ting Hong,Yan Bi,Zhijuan Ge,Yinyan Tangsun,Wenjuan Tang,Dalong Zhu
DOI: https://doi.org/10.3760/cma.j.issn.1674-5809.2016.04.009
2016-01-01
Abstract:Objective To investigate the effects of erythropoietin (EPO) on hepatic lipid metabolism and explore the underlying mechanism. Methods Twelve eight-week female ob/ob mice were randomly divided into two groups according to random number table and treated intraperitoneally with 3 000 U/kg recombinant human EPO (ob/ob+EPO group, n=6) and phosphate buffer saline(PBS) (ob/ob+PBS group, n=6), respectively. Lean littermate C57BL/6 mice were selected as normal control (C57BL/6 group,n=6). Human hepatoma cell line HepG2 cells were intervened with palmitic acid (PA, 0.5 mmol/L) and different concentrations of EPO(5 or 10 U/ml). HepG2 cells were divided into four groups: control(no-treating), PA, PA+EPO (5 U/ml) and PA+EPO (10 U/ml) group. Steatosis of hepatic cells was observed by oil red O staining. The expression of erythropoietin receptor (EPOR), sterol regulatory element-binding protein-1c (SREBP-1c), fatty acid synthase (FAS), acetyl CoA carboxylase (ACC) and carnitine palmitoyltransferase 1a (CPT-1a) were detected in mice and HepG2 cells by Western blotting mothods. One-way analysis of variance or least significant difference test were used for data analysis. Results Reduced lipid accumulation in hepatic cells with EPO treatment was observed by oil red O staining in vivo and in vitro. The protein levels of&nbsp;SREBP-1c, FAS and ACC in ob/ob+EPO group decreased significantly (0.78±0.08 vs 1.23±0.03, 1.03±0.08 vs 1.16 ± 0.01, 1.10 ± 0.33 vs 1.69 ± 0.02, t=-6.906,-2.756,-8.794, all P<0.05), while the protein levels of EPOR and CPT-1a increased significantly (1.28 ± 0.14 vs 0.97 ± 0.06, 0.77 ± 0.06 vs 0.60 ± 0.12, t=2.749, 2.655, all P<0.05 ) when compared with those in PBS controls. The protein levels of SREBP-1c, FAS and ACC in PA+EPO (10 U/ml) group decreased remarkably (t=-10.731,-2.760,-9.618, all P<0.05), while the protein levels of EPOR and CPT-1a increased markedly(t=7.556,2.674, all P<0.05) when compared with those in PA group. Conclusion EPO may alleviate the excessive lipid deposition in the liver via inhibiting lipogenesis and promoting fatty acid oxidation.
What problem does this paper attempt to address?